News|Articles|November 19, 2026

How Medicine Moves: The Invisible Infrastructure Behind Every Dose

Author(s)Gene Cavacini
Listen
0:00 / 0:00

Key Takeaways

  • U.S. pharmaceutical distributors process most national medication volume, consolidating supply from 1,400+ manufacturers and delivering daily to pharmacies, hospitals, clinics, infusion sites, and homes.
  • Shortages, though affecting a minority of prescriptions, drive clinically meaningful delays and operational burden; network-wide visibility enables earlier detection and targeted redistribution to stabilize supply.
SHOW MORE

McKesson's Gene Cavacini on how pharmaceutical distributors manage drug shortages, DSCSA requirements and cold-chain capacity to keep medicines moving.

Every day, medicines take a carefully coordinated journey. They leave a manufacturer, move through secure, temperature-controlled facilities and arrive at the point of care, whether that’s a pharmacy counter, hospital or clinic, infusion site or even a patient’s home.

According to a 2025 report from the Health care Distribution Alliance Research Foundation and Deloitte, pharmaceutical distributors handle roughly 96% of all medication volume across the U.S., processing more than 135 million orders annually.¹ Distributors aggregate medicines from more than 1,400 manufacturers and deliver them daily to pharmacies, hospitals, clinics and other care settings.¹ The numbers are large, but what they represent is straightforward: behind every filled prescription is a distribution network working nonstop to keep the system running.

Distribution doesn’t pause. Even when there’s a severe weather event, a natural disaster or a global pandemic, medicines still need to reach the patients who need them. Pharmaceutical distributors keep medicines moving safely and reliably across the health care supply chain, a role most people never see, but millions rely on every day.

When Supply Runs Short

Drug shortages affect a relatively small number of prescriptions, but the impact can be significant: delayed treatment for patients, disruptions in medical procedures and a costly labor burden on hospitals scrambling to work around gaps.

Because distributors have visibility across the entire health care supply chain, we’re uniquely positioned to help combat shortages. We use advanced tools, including predictive analysis and AI, to identify vulnerabilities and early warning signs of a potential shortage, allowing us to redirect supply, strengthen capacity and stabilize the system before strain becomes a crisis. When supply constraints do occur, we work diligently to ensure the distribution of available products to the patients who are counting on them.

When supply is constrained, no single player can solve the problem. What helps most is coordination and transparent communication among manufacturers, providers, distributors and government partners. Through enhanced, responsible data sharing, we can provide visibility across the supply chain to support safety and surety of supply while identifying and preempting vulnerabilities.

Why Every Second Counts

Recently a children’s hospital contacted McKesson with an urgent request. A young patient recovering from cancer surgery needed a critical medication during a nationwide shortage. Only a handful of vials remained in our network, spread across distant locations, and the request came in after standard shipping cutoffs.

Within hours, teams worked across multiple sites to locate the vials, arrange emergency transport and deliver them in under 24 hours. Our team’s expertise, dedication and commitment to patients made all the difference. For their doctor, the difference between staying on the intended treatment or delaying care. For the patient and their family, the difference between peace of mind and enduring another day of uncertainty.

What Is the Complexity Challenge?

A common misconception is that when distribution works, it must be simple. In reality, reliability only exists because complexity is well managed. When the system functions as intended, hospitals don’t need to hold excess drug inventory, and pharmacies don’t need to chase multiple sources for routine supply. That reliability depends on a tightly regulated network coordinating the storage and movement of thousands of products, from everyday generics to specialty therapies with strict handling requirements.

Security is part of this, too. The Drug Supply Chain Security Act (DSCSA) required the establishment of a standardized system for tracking pharmaceutical products to bolster patient safety and safeguard against counterfeit drugs.² Each added requirement introduces more complexity. Meeting these demands requires purpose-built infrastructure and ongoing investment in that infrastructure, as well as in automation, data integration and real-time monitoring.

The Supply Chain of the Future Starts Today

The role of distributors will become even more critical as we look ahead and consider the exciting advancements in the pharmaceutical pipeline. Cell and gene therapies are rewriting what's possible for patients with previously untreatable conditions. Biologics, mRNA vaccines and personalized medicines are arriving at a pace that would have been unimaginable a generation ago. The promise of these therapies is enormous, and so is the task of delivering on that promise.

Many medicines require tightly controlled environments, shorter shelf lives, tighter chains of custody and detailed documentation to ensure safety and meet regulation requirements. Distributors have been preparing for these advancements for years by investing in cold-chain capacity, automation and the data infrastructure needed for modern therapies. The therapies on the horizon are remarkable, and our ability to get them in the hands of the patients who need them is there.

As therapies continue to advance and patient needs evolve, distributors will remain the connective tissue that holds our health care supply chain together. With our scale, reach and strong partnerships, distributors will continue building and powering the supply chain of the future to keep pace with the medical innovations it delivers.

Distributors have been a vital part of health care infrastructure for generations, and we’ll continue rising to the challenge of ensuring medicines reach the places they’re needed safely and reliably.

Gene Cavacini is president of U.S. pharmaceutical distribution at McKesson.

References

1. The Role of Distributors in the U.S. Health Care Industry. HDA Research Foundation, Deloitte. 2025. Accessed Nov. 19, 2026. https://hda.org/publications/the-role-of-distributors-in-the-us-healthcare-industry/

2. Drug Supply Chain Security Act (DSCSA). U.S. Food and Drug Administration. Accessed Nov. 19, 2026. https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa


Related to this article